Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial

IMPORTANCE: Patients with symptomatic lower extremity peripheral artery disease (LE-PAD) experience an increased risk of major vascular events. There is limited information on what clinical features of symptomatic LE-PAD prognosticate major vascular events and whether patients at high risk have a gr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Cardiol
Asıl Yazarlar: Kaplovitch, Eric, Eikelboom, John W., Dyal, Leanne, Aboyans, Victor, Abola, Maria Teresa, Verhamme, Peter, Avezum, Alvaro, Fox, Keith A. A., Berkowitz, Scott D., Bangdiwala, Shrikant I., Yusuf, Salim, Anand, Sonia S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2020
Konular:
Original Investigation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527938/
https://ncbi.nlm.nih.gov/pubmed/32997098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.4390
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller